HCPCS Code C1826: Implantable neurostimulator generator billing guide

Key takeaways

HCPCS Code C1826 describes a generator, neurostimulator (implantable), that includes closed feedback loop leads and all implantable components, with a rechargeable battery and charging system.

C1826 is a C-code limited to ASC and hospital outpatient department (HOPD) settings. It cannot be billed in a physician office or inpatient setting.

Choosing the wrong device descriptor, rechargeable versus nonrechargeable, is the most common billing error for neurostimulator C-codes. Always verify the device label before coding.

For 2026, C1826’s device pass-through and separate payment status have expired. Medicare now packages its payment into the primary procedure instead of a separate line item.

Practice management software like Pabau helps billing teams submit, track, and record insurance claims and payments from one dashboard.

HCPCS Code C1826 is a billable device code for a generator, neurostimulator (implantable). The descriptor includes closed feedback loop leads and all implantable components, with a rechargeable battery and charging system.

Medicare pays for it only under the Outpatient Prospective Payment System (OPPS) or the Ambulatory Surgical Center (ASC) payment system. Payment also depends on billing it in the correct facility setting with the right documentation.

This guide covers the code descriptor, covered settings, 2026 payment rules, related codes, and the documentation checklist that keeps claims clean.

HCPCS Code C1826: Definition and clinical description

According to the Centers for Medicare and Medicaid Services (CMS), the HCPCS code set assigns C1826 the following official long descriptor:

Each word in that descriptor has billing significance. “Rechargeable” distinguishes this device from nonrechargeable IPGs, which are coded separately under C1823.

“Closed feedback loop” specifies the sensing architecture that automatically adjusts stimulation based on a monitored physiological signal. Substituting a synonym or omitting a descriptor element makes the code unverifiable against the device label. That mismatch is the most common trigger for a C-code audit.

What device does C1826 describe?

C1826 covers an implantable pulse generator (IPG) built around a closed feedback loop. The device continuously senses a physiological signal and automatically adjusts its stimulation output, rather than delivering a fixed, open-loop signal.

The HCPCS descriptor bundles the leads and all other implantable components together with the generator under this single code.

The rechargeable designation means the device pairs with an external charging system. Patients use it to recharge the implanted battery transcutaneously, extending the generator’s usable life well beyond a primary-cell design.

Nonrechargeable IPGs, which run on a primary cell battery that is replaced once depleted, are coded separately under C1823. Billing the wrong rechargeability type is a frequent source of claim denial, so verifying this detail against the device implant log before coding is essential.

Covered clinical settings: ASC and HOPD

C-codes are setting-specific. HCPCS Code C1826 is valid only in two facility settings under Medicare: the Ambulatory Surgical Center (ASC) and the Hospital Outpatient Department (HOPD). Submitting this code on a professional claim or in an inpatient setting results in a rejection. The code is structurally invalid outside these two contexts.

Both valid settings submit C1826 on a UB-04 institutional claim form, but the payment mechanism differs. HOPDs are reimbursed under the OPPS APC system, while ASCs use the Medicare ASC payment schedule.

That distinction affects the rate, the payment status indicator, and whether the device is separately payable or packaged. Billing teams managing outpatient facility claims need to confirm which payment pathway applies before submission to avoid rework.

Neurostimulator implants span several specialties. Physical therapy practices often coordinate post-implant rehabilitation, while pelvic health practices bill a related C-code family for sacral nerve stimulators.

Medicare OPPS payment for HCPCS Code C1826

Under the Medicare Outpatient Prospective Payment System, hospital outpatient departments are reimbursed for C1826 based on the device’s Ambulatory Payment Classification (APC) assignment. The APC groups the device with other procedures and supplies of similar clinical complexity and cost.

CMS assigns a payment status indicator (SI) to each HCPCS code under OPPS. For implantable device codes like C1826, the SI determines whether the device is:

• Separately payable: the device is reimbursed independently of the associated procedure’s APC
• Packaged: the device cost is bundled into the APC payment for the primary procedure, with no separate line-item payment
• Conditionally packaged: the device is packaged when billed with a surgical procedure but may be separately payable when billed alone

APC assignments and payment status indicators are updated annually through the OPPS final rule published in the Federal Register.

For 2026, CMS ended C1826’s device pass-through and separate payment status. Under CMS Transmittal MM14361, the device’s payment is now packaged into the primary procedure, with no separate line-item payment for dates of service in 2026.

Coders and billing teams should verify C1826’s current SI against CMS’s OPPS payment files for the applicable calendar year. Static, prior-year reference data may not reflect current packaging or reimbursement rules.

HCPCS Code C1826 fee schedule 2026 and ASC payment

In the ASC setting, HCPCS Code C1826 is reimbursed under the Medicare ASC payment system, which maintains its own APC-based rates distinct from OPPS. ASC rates for device codes are generally set as a percentage of the OPPS rate. Like OPPS, ASC rates are updated each January 1 through the annual payment system final rule.

The ASC payment system saw the same change under CMS Transmittal MM14359. C1826’s separate payment status also ended December 31, 2025, so ASC facilities now bill the device as packaged into the primary procedure, not as a separate line item.

C1826’s current payment status should be verified directly against CMS Addendum AA (ASC payment rates) and CMS OPPS Addendum B (HOPD OPPS rates). These are the authoritative source documents for the current calendar year.

Third-party reference tools can be useful for a quick lookup, but always cross-reference CMS source files before submitting a claim. That check matters most for high-cost implantable devices, where the dollar variance between years can be substantial.

Commercial payer rates for C1826 are negotiated separately and are not governed by the Medicare fee schedule. Many commercial contracts reference Medicare rates as a baseline percentage, for example 110% of Medicare OPPS. The exact rate still must be confirmed with each payer contract.

The same systematic verification applies to other device and supply codes, including HCPCS Code A6242. Billing teams can confirm which rate applies before submitting a claim.

Medicare coverage and reimbursement considerations

Medicare coverage for the C1826 device is governed by applicable Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs) related to the underlying clinical procedure. Coverage for the generator itself is generally tied to coverage of the associated neurostimulator implant procedure. If the procedure is covered, the device is covered as a component of it.

Several coverage considerations apply when billing C1826 under Medicare Part B in an outpatient facility setting:

• LCD/NCD alignment: The procedure and device must meet the clinical criteria outlined in any applicable LCD for neurostimulation. Missing a required diagnosis code or indication can cause the device claim to deny even when the procedure claim processes.
• Prior authorization: Medicare fee-for-service does not typically require prior authorization for HCPCS device codes in ASC or HOPD settings, but Medicare Advantage plans vary significantly. Verify the specific plan’s requirements before the procedure date.
• Medical necessity documentation: The medical record must support the clinical indication for the device. Payer auditors reviewing C-code claims for implantable devices will scrutinize whether the device descriptor matches the device implanted. They also check whether medical necessity was established before the procedure.
• Medicare Part B deductible and coinsurance: Patients are subject to standard Medicare Part B cost-sharing for outpatient facility claims that include separately payable device codes.

Teams managing compliance documentation can reduce coverage denials on high-cost implantable device claims by building a checklist for each C-code type.

Related and crosswalk HCPCS codes for neurostimulator devices

Choosing the right HCPCS C-code for a neurostimulator device depends on the specific device characteristics. Several codes in the C1800-series cover related implantable neurostimulator components. Each has a distinct descriptor that corresponds to a device attribute.

Using the AAPC HCPCS code lookup alongside the device implant documentation helps confirm the correct code before claim submission. Billing teams building this C-code reference can also consult the newly published HCPCS Code C1880 guide for another ASC and HOPD device example.

C1778 covers the lead component separately from the generator. In some procedures, both the generator (C1826) and leads (C1778) may be billed on the same claim when both are implanted and separately reportable. Verify whether the payer considers these bundled or separately reimbursable before billing both on the same date of service.

C1823 uses a similar descriptor structure, but it reports the nonrechargeable, transvenous-lead version of the generator. Confirm the device’s rechargeability and lead configuration against the label before choosing between C1826 and C1823.

Teams building out procedure code reference libraries for outpatient surgical billing benefit from documenting the complete C-code family for each device type they implant. That includes predecessor and successor codes from prior HCPCS annual updates.

Documentation requirements for billing C1826

Clean documentation is the foundation of a defensible C1826 claim. Payer auditors reviewing high-cost implantable device claims, particularly under Medicare Recovery Audit Contractor (RAC) reviews, will request the full medical record. Missing one of these elements can result in a denial on post-payment audit even after the initial claim has paid.

• Operative note: Must document the specific device implanted, including manufacturer, model number, and serial number. The operative note is the primary source used to verify the code descriptor matches the implanted device.
• Device implant log (charge capture log): The facility’s implant log should record the same manufacturer, model, and serial information as the operative note. Discrepancies between the two documents are a red flag in audits.
• Device label or sticker: Many facilities affix the manufacturer device label directly to the operative record. This label confirms the HCPCS-relevant device attributes: rechargeability type, lead configuration, and intended implant site.
• Pre-procedure clinical documentation: Medical records must support the clinical indication for the neurostimulator. Relevant diagnosis codes submitted with C1826 must align with covered LCD/NCD indications.
• Prior authorization documentation: If Medicare Advantage or a commercial payer required prior authorization, attach the approval reference number. Missing prior auth documentation causes an administrative denial separate from the clinical review.
• Attending physician order: The order for the procedure and device must be present in the record and signed by the responsible physician.

Facilities using structured clinical documentation workflows can build device-specific documentation checklists directly into their pre-procedure intake process. That way, every required element is captured before the operative date rather than reconstructed afterward.

ASC coding for implantable devices: C-code rules and common errors

C-codes occupy a specific structural niche within HCPCS Level II. Unlike supply codes (A-codes) or drug codes (J-codes), C-codes are created specifically for ASC and HOPD settings. They are tied to the CMS OPPS and ASC payment systems.

A supply coded with a C-code in a physician office setting is an invalid submission. The code set was designed for facility billing, not professional billing. Understanding this context prevents one of the most common structural errors in outpatient implant coding.

Common coding errors and how to avoid them

According to the NLM HCPCS reference, C-codes require exact descriptor matching against the implanted device. The errors below account for most C-code claim denials and post-payment audit findings for neurostimulator implants:

Facilities implementing EHR-to-billing integration workflows can build validation rules directly into charge capture. Those rules flag C-code submissions on professional claim forms, or an incomplete device documentation checklist, before the claim leaves the facility.

The same scrutiny applies to add-on codes billed the same day, such as CPT Code 11001, where bundling rules decide if it’s billable separately.

How Pabau keeps claims submission and tracking simple

Practices billing high-cost device claims like C1826 often juggle a payer portal, a spreadsheet for claim status, and a separate system for tracking payments once they land. Every handoff between those tools is a chance to lose track of a claim.

Pabau’s claims management software, a feature of the core platform, lets a practice submit a claim and watch its status move from pending to paid. It records the payment against the right invoice, all from one dashboard. Built-in checks flag missing details, like an incomplete membership number, before the claim goes out.

That means less time re-submitting rejected claims and less time chasing a payer for a status update. For a practice handling a mix of code types, one system that tracks every claim end to end removes a common source of billing errors.

Simplify claims submission and tracking

Pabau's claims management software lets your team submit, track, and record insurance claims and payments from one dashboard. Built-in checks catch missing details before a claim goes out.

Book a demo

Conclusion

HCPCS Code C1826 is a precision billing instrument. The difference between a clean claim and an audit flag often comes down to one phrase in the device descriptor.

Confirm whether the device is rechargeable or nonrechargeable, and whether the leads use a closed feedback loop or a transvenous configuration. Match every word in the descriptor against the operative note and device label.

Getting the device descriptor right the first time avoids the downstream costs: resubmission, audit review, and delayed reimbursement. Book a demo to see how Pabau keeps claims moving from submission to payment.

Continue your research

Coding DME and nutritional supply claims too? HCPCS Code B4100 covers the same kind of single-purpose descriptor matching for oral nutritional supplies.

Billing insulin pump supplies for patients? HCPCS Code A4231 walks through the documentation rules for external insulin pump infusion sets.

Coding facial rejuvenation procedures? CPT Code 15824 covers billing rules for a forehead and brow lift.

Handling anesthesia billing for orthopedic cases? CPT Code 01630 breaks down anesthesia billing for shoulder arthroplasty.

Frequently asked questions